Your browser doesn't support javascript.
loading
Anxiety, concerns and COVID-19: Cross-country perspectives from families and individuals with neurodevelopmental conditions.
Sideropoulos, Vassilis; Van Herwegen, Jo; Meuleman, Ben; Alessandri, Michael; Alnemary, Faisal M; Rad, Jamal Amani; Lavenex, Pamela A Banta; Bolshakov, Nikita; Bölte, Sven; Buffle, Paulina; Cai, Ru Y; Campos, Ruth; Chirita-Emandi, Adela; Costa, Andreia P; Costanzo, Floriana; Des Portes, Vincent; Dukes, Daniel; Faivre, Laurence; Famelart, Nawelle; Fisher, Marisa H; Gamaiunova, Liudmilla; Giannadou, Aikaterini; Gupta, Rashmi; Hardan, Antonio Y; Houdayer-Robert, Françoise; Hrncirova, Lenka; Iaochite, Roberto Tadeu; Jariabkova, Katarina; Klein-Tasman, Bonita P; Lavenex, Pierre; Malik, Supriya; Mari, Francesca; Martinez-Castilla, Pastora; Menghini, Deny; Nuske, Heather J; Palikara, Olympia; Papon, Anouk; Pegg, Robin S; Pouretemad, Hamidreza; Poustka, Luise; Prosetzky, Ingolf; Renieri, Alessandra; Rhodes, Sinead M; Riby, Deborah M; Rossi, Massimiliano; Sadeghi, Saeid; Su, Xueyen; Tai, Claire; Tran, Michel; Tynan, Fionnuala.
Afiliación
  • Sideropoulos V; Department of Psychology and Human Development, IOE, UCL's Faculty of Education and Society, London, UK.
  • Van Herwegen J; Department of Psychology and Human Development, IOE, UCL's Faculty of Education and Society, London, UK.
  • Meuleman B; Swiss Center for Affective Sciences, University of Geneva, Geneva, Switzerland.
  • Alessandri M; Department of Psychology, University of Miami, Coral Gables, Florida, USA.
  • Alnemary FM; Autism Center of Excellence, Riyadh, Kingdom of Saudi Arabia.
  • Rad JA; Department of Cognitive Modeling, Institute for Cognitive and Brain Sciences, Shahid Beheshti University, Tehran, Iran.
  • Lavenex PAB; Faculty of Psychology, UniDistance Suisse, Brig, Switzerland.
  • Bolshakov N; Independent researcher.
  • Bölte S; Center of Neurodevelopmental Disorders at Karolinska Institutet (KIND), Center for Psychiatry Research, Department of Women's and Children's Health, Stockholm, Sweden.
  • Buffle P; Laboratory of Sensori-Motor Affective and Social Development, Faculty of Psychology and Educational Sciences, University of Geneva, Geneva, Switzerland.
  • Cai RY; Aspect Research Centre for Autism Practice, Autism Spectrum Australia, Frenchs Forest, New South Wales, Australia.
  • Campos R; Department of Basic Psychology, Faculty of Psychology, Universidad Autónoma de Madrid, Madrid, Spain.
  • Chirita-Emandi A; Department of Microscopic Morphology - Genetics, Center of Genomic Medicine, University of Medicine and Pharmacy "Victor Babes" Timisoara, Timisoara, Romania.
  • Costa AP; Department of Behavioural and Cognitive Sciences, University of Luxembourg, Luxembourg.
  • Costanzo F; Child and Adolescents Neuropsychiatry Unit, Bambino Gesù Children's Hospital, Rome, Italy.
  • Des Portes V; National Reference Center for Intellectual Disabilities of Rare causes, Lyon University Hospital, France.
  • Dukes D; Institute of Special Education, University of Fribourg, Fribourg, Switzerland.
  • Faivre L; Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs, FHU TRANSLAD, INSERM UMR1231, Hôpital d'Enfants, CHU Dijon, Dijon Cedex, France.
  • Famelart N; Laboratory CLLE, University of Toulouse, CNRS, Toulouse, France.
  • Fisher MH; Department of Counselling, Educational Psychology, & Special Education, Michigan State University, East Lansing, Michigan, USA.
  • Gamaiunova L; Institute for Social Sciences of Religions, University of Lausanne, Lausanne, Switzerland.
  • Giannadou A; Cabinet office, London, UK.
  • Gupta R; Cognitive and Behavioural Neuroscience Laboratory, Department of Humanities and Social Sciences, Indian Institute of Technology Bombay, Mumbai, Powai, Maharashtra, India.
  • Hardan AY; Department of Psychiatry and Behavioural Sciences, Stanford University, Stanford, California, USA.
  • Houdayer-Robert F; Genetics Department, Reference Centre for Developmental Disorders Centre East, Bron, France.
  • Hrncirova L; Department of Special and Inclusive Education, Faculty of Education, Masaryk University, Brno, Czech Republic.
  • Iaochite RT; Department of Education, Sao Paulo State University (UNESP), Rio Claro, Brazil.
  • Jariabkova K; Institute for Research in Social Communication, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Klein-Tasman BP; University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
  • Lavenex P; Laboratory of Brain and Cognitive Development, Institute of Psychology, University of Lausanne, Lausanne, Switzerland.
  • Malik S; eMbrace, New Delhi, India.
  • Mari F; Medical Genetics, University of Siena, Siena, Italy.
  • Martinez-Castilla P; Department of Developmental and Educational Psychology, Universidad Nacional de Educación a Distancia (UNED), Madrid, Spain.
  • Menghini D; Child and Adolescents Neuropsychiatry Unit, Bambino Gesù Children's Hospital, Rome, Italy.
  • Nuske HJ; Penn Center for Mental Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Palikara O; Department of Education Studies, Faculty of Social Sciences, University of Warwick, Warwick, UK.
  • Papon A; Faculty of Psychology, UniDistance Suisse, Brig, Switzerland.
  • Pegg RS; Williams Syndrome Association, Troy, Michigan, USA.
  • Pouretemad H; Department of Cognitive Psychology, Institute for Cognitive and Brain Sciences, Shahid Beheshti University, Tehran, Iran.
  • Poustka L; Department of Child and Adolescent Psychiatry and Psychotherapy, University Medical Centre Göttingen, Göttingen, Germany.
  • Prosetzky I; Faculty of Social Sciences, University of Applied Sciences Zittau / Görlitz, Görlitz, Germany.
  • Renieri A; Medical Genetics, University of Siena, Siena, Italy.
  • Rhodes SM; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
  • Riby DM; Department of Psychology, Centre for Neurodiversity & Development, Durham University, Durham, UK.
  • Rossi M; Service de génétique HCL, INSERM U1028, CNRS UMR5292, CRNL, GENDEV Team, UCBL1, Bron, France.
  • Sadeghi S; Department of Cognitive Psychology, Institute for Cognitive and Brain Sciences, Shahid Beheshti University, Tehran, Iran.
  • Su X; Department of Early Childhood Education, Faculty of Education, East China Normal University, Shanghai, China.
  • Tai C; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
  • Tran M; Faculty of Psychology, UniDistance Suisse, Brig, Switzerland.
  • Tynan F; Faculty of Education, Mary Immaculate College, Limerick, Ireland.
J Glob Health ; 13: 04081, 2023 Jul 28.
Article en En | MEDLINE | ID: mdl-37497751
ABSTRACT

Background:

The COVID-19 pandemic had a major impact on the mental health and well-being of children with neurodevelopmental conditions (NDCs) and of their families worldwide. However, there is insufficient evidence to understand how different factors (e.g., individual, family, country, children) have impacted on anxiety levels of families and their children with NDCs developed over time.

Methods:

We used data from a global survey assessing the experience of 8043 families and their children with NDCs (mean of age (m) = 13.18 years, 37% female) and their typically developing siblings (m = 12.9 years, 45% female) in combination with data from the European Centre for Disease Prevention and Control, the University of Oxford, and the Central Intelligence Agency (CIA) World Factbook, to create a multilevel data set. Using stepwise multilevel modelling, we generated child-, family- and country-related factors that may have contributed to the anxiety levels of children with NDCs, their siblings if they had any, and their parents. All data were reported by parents.

Results:

Our results suggest that parental anxiety was best explained by family-related factors such as concerns about COVID-19 and illness. Children's anxiety was best explained by child-related factors such as children's concerns about loss of routine, family conflict, and safety in general, as well as concerns about COVID-19. In addition, anxiety levels were linked to the presence of pre-existing anxiety conditions for both children with NDCs and their parents.

Conclusions:

The present study shows that across the globe there was a raise in anxiety levels for both parents and their children with NDCs because of COVID-19 and that country-level factors had little or no impact on explaining differences in this increase, once family and child factors were considered. Our findings also highlight that certain groups of children with NDCs were at higher risk for anxiety than others and had specific concerns. Together, these results show that anxiety of families and their children with NDCs during the COVID-19 pandemic were predicted by very specific concerns and worries which inform the development of future toolkits and policy. Future studies should investigate how country factors can play a protective role during future crises.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pandemias / COVID-19 Tipo de estudio: Prognostic_studies Límite: Adolescent / Female / Humans / Male Idioma: En Revista: J Glob Health Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pandemias / COVID-19 Tipo de estudio: Prognostic_studies Límite: Adolescent / Female / Humans / Male Idioma: En Revista: J Glob Health Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido